Winton Group LTD Sage Therapeutics, Inc. Transaction History

Winton Group LTD

$1.35 Billion
Q4 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$37.27 - $46.57 $143,414 - $179,201	3,848 Added 24.81%	19,356 $812,000
Q4 2022 Feb 14, 2023	BUY	$32.2 - $43.61 $11,914 - $16,135	370 Added 2.44%	15,508 $591,000
Q3 2022 Nov 10, 2022	SELL	$32.28 - $43.27 $58,781 - $78,794	-1,821 Reduced 10.74%	15,138 $593,000
Q2 2022 Aug 10, 2022	BUY	$27.52 - $37.99 $90,458 - $124,873	3,287 Added 24.04%	16,959 $548,000
Q1 2022 May 11, 2022	BUY	$30.71 - $45.71 $68,974 - $102,664	2,246 Added 19.66%	13,672 $453,000
Q4 2021 Feb 10, 2022	SELL	$37.06 - $47.11 $997,729 - $1.27 Million	-26,922 Reduced 70.2%	11,426 $486,000
Q3 2021 Oct 28, 2021	BUY	$40.26 - $57.37 $769,288 - $1.1 Million	19,108 Added 99.31%	38,348 $1.7 Million
Q2 2021 Aug 10, 2021	BUY	$54.88 - $79.29 $571,191 - $825,250	10,408 Added 117.84%	19,240 $1.09 Million
Q1 2021 Jul 21, 2021	SELL	$70.65 - $96.76 $138,403 - $189,552	-1,959 Reduced 18.15%	8,832 $661,000
Q4 2020 Feb 12, 2021	SELL	$58.41 - $89.06 $2.33 Million - $3.55 Million	-39,886 Reduced 78.71%	10,791 $934,000
Q3 2020 Oct 30, 2020	SELL	$41.13 - $62.45 $235,839 - $358,088	-5,734 Reduced 10.16%	50,677 $3.1 Million
Q2 2020 Aug 05, 2020	BUY	$25.95 - $43.15 $1.46 Million - $2.43 Million	56,411 New	56,411 $2.35 Million
Q1 2020 May 11, 2020	SELL	$26.15 - $77.24 $487,932 - $1.44 Million	-18,659 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$60.18 - $154.77 $947,233 - $2.44 Million	15,740 Added 539.23%	18,659 $1.35 Million
Q3 2019 Nov 08, 2019	BUY	$140.29 - $189.96 $409,506 - $554,493	2,919 New	2,919 $410,000
Q1 2019 May 13, 2019	SELL	$89.33 - $163.65 $239,404 - $438,582	-2,680 Closed	0 $0
Q4 2018 Feb 05, 2019	SELL	$81.94 - $139.71 $66,453 - $113,304	-811 Reduced 23.23%	2,680 $257,000
Q3 2018 Nov 02, 2018	BUY	$138.11 - $169.04 $95,157 - $116,468	689 Added 24.59%	3,491 $0
Q2 2018 Aug 20, 2018	SELL	$140.36 - $175.76 $109,200 - $136,741	-778 Reduced 21.73%	2,802 $0
Q1 2018 May 21, 2018	BUY	$152.15 - $192.33 $544,697 - $688,541	3,580 New	3,580 $0

Others Institutions Holding SAGE

# of Institutions

194

Shares Held

45M

Call Options Held

304K

Put Options Held

117K

View Full List

About Sage Therapeutics, Inc.

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $440M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

More about SAGE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Winton Group LTD with notifications on news.

Account